Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

RxE2 Appoints Lori Doele Director of Business Development


News provided by

RxE2

15 Sep, 2020, 14:00 IDT

Share this article

Share toX

Share this article

Share toX

FARGO, North Dakota, Sept. 15, 2020 /PRNewswire/ -- RxE2 announced today that Lori Doele has joined the company as its new director of business development.

Lori will be responsible for managing RxE2's partnerships with pharmaceutical and medical device clinical study sponsors.

Continue Reading
Lori Doele, Director, Business Development, RxE2
Lori Doele, Director, Business Development, RxE2

Following a successful 30-year career in banking, Lori ventured to the clinical research industry in 2011. Over the years she has worked in sales, project management and business development, including as the director of business development –West Coast office at Clinical Supplies Management (CSM), founded by Gerald Finken.

Ms. Doele said, "From my experience at CSM, I personally know the depth and possibilities of Gerald's vision.  CSM is an example of how he built a multi-million business from an idea and changed the way drugs were packaged and delivered. Gerald's current initiative to make clinical trials available to everyone, everywhere by incorporating the practice of pharmacy is both simple and transformative.  It is certain to change the way clinical trials are conducted, for the benefit of patients and study sponsors alike. I look forward to serving as the point person for future collaborations."

RxE2 CEO Gerald Finken, R.Ph., M.S. said, "During the past six months, RxE2 has been building its infrastructure. We began by introducing our E2 Dispensing services in partnership with Thrifty White Pharmacy in the United States and in partnership with Newdays Pharmacies in the UK and the European Union. During this time we also hired Tina Schlecht, Pharm. D., to be our Vice President of Pharmacy Operations. With the addition of Lori Doele to our team, the four corner stones of RxE2's E2 dispensing services are now in place and we are officially ready to service our partners sponsoring clinical trials on both sides of the Atlantic."

About RxE2

RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists, as trusted medication experts, to use their extensive patient insights to make clinical trials more accessible for qualifying patients, everywhere, to vastly reduce clinical trial timelines and costs, to help patients achieve higher quality outcomes and study sponsors more accurate data. To learn more, please visit www.Rx-E2.com.

Photo - https://mma.prnewswire.com/media/1274508/RxE2_Lori_Doele.jpg

Press Contact:

Marjie Hadad
General Manager
Must Have Communications
[email protected] 
917-790-1178

SOURCE RxE2

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.